Consistently, in breast cancer tissues, there were lower levels of RPH3AL protein in malignant breast cells (LIN, DCIS, and invasive carcinoma) relative to nonmalignant cells. This evidence concerns the gene RPH3AL and ductal breast carcinoma in situ.